Charles Henrikson is a Cardiology physician affiliated with Oregon Health & Science University. OpenAlex indexes 256 publications with 7,218 citations (h-index 46); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Division Of Cardiology Uhn 62
Portland, OR 972393011
Telephone
503-494-8750Registry record last updated 16 Sept 2011.
Clinical trials
- The Z Stitch Early Bed Rest Assessment Study
Sponsor: Oregon Health and Science University
- VAPORHCS/OHSU J: MRI and Devices
Sponsor: Oregon Health and Science University
- LV Dysfunction Following Pacemaker Placement
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Philips North America LLCProgram year20251 payment
- GE HEALTHCAREProgram year20251 payment
- Medtronic, Inc.Program year20248 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62.4%Beta blocker34.4%Metoprolol Succinate57%Sotalol32%Metoprolol Tartrate11%Part D<11 patientsAntiarrhythmic28%Dofetilide41%Amiodarone Hcl33%Flecainide Acetate27%Part D≥18 patientsBlood & clotting
37.6%Factor Xa inhibitor30.7%Eliquis82%Xarelto19%Part D<11 patientsP2Y12 inhibitor6.9%Clopidogrel100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Stellate Ganglion Blockade With Continuous Infusion Versus Single Injection for Treatment of Ventricular Arrhythmia Storm
JACC. Clinical electrophysiology
2020 - Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators
Journal of the American College of Cardiology
2018 - Standard Ablation Versus Magnetic Resonance Imaging–Guided Ablation in the Treatment of Ventricular Tachycardia
Circulation Arrhythmia and Electrophysiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”